XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment Information (Tables)
9 Months Ended
Sep. 30, 2022
Segment Information  
Schedule of information about reportable segments

The following table presents information about our reportable segments for the three months ended September 30, 2022 and 2021 (in thousands):

Three months ended September 30, 

    

2022

2021

    

US

    

Ex-US

    

Total

    

US

    

Ex-US

    

Total

    

Product revenue

$

23,019

$

7,644

$

30,663

$

28,699

$

9,217

$

37,916

Operating expenses:

 

  

 

  

 

  

 

  

 

  

 

  

Cost of sales - product

 

4,487

 

2,778

 

7,265

 

5,488

 

3,018

 

8,506

Cost of sales - intangible asset amortization

 

620

 

723

 

1,343

 

620

 

723

 

1,343

Research and development

 

29,122

 

1,665

 

30,787

 

44,309

 

1,913

 

46,222

Selling, general and administrative

 

25,872

 

4,508

 

30,380

 

26,685

 

5,511

 

32,196

Acquired in-process research and development

3,272

3,272

Other operating expenses

5,123

5,123

3,841

3,841

Total expenses

 

65,224

 

 

9,674

 

 

74,898

 

 

84,215

 

 

11,165

 

 

95,380

 

Operating loss

$

(42,205)

$

(2,030)

(44,235)

$

(55,516)

$

(1,948)

(57,464)

Other income (expense):

Interest expense

(9,863)

(8,786)

Foreign currency loss

(2,073)

(1,248)

Other income

192

101

Other income (expense), net

(11,744)

(9,933)

Loss before income taxes

(55,979)

(67,397)

Income tax benefit (expense)

(35)

(13)

Net loss

$

(56,014)

$

(67,410)

Nine months ended September 30, 

    

2022

2021

    

US

    

Ex-US

    

Total

    

US

    

Ex-US

    

Total

    

Product revenue

$

70,262

$

26,790

$

97,052

$

88,080

$

24,709

$

112,789

Operating expenses:

 

  

 

  

 

  

 

  

 

  

 

  

Cost of sales - product

 

13,782

 

9,425

 

23,207

 

17,047

 

8,021

 

25,068

Cost of sales - intangible asset amortization

 

1,861

 

2,168

 

4,029

 

1,860

 

2,168

 

4,028

Research and development

 

103,996

 

5,467

 

109,463

 

138,913

 

5,873

 

144,786

Selling, general and administrative

 

76,365

 

15,818

 

92,183

 

77,357

 

17,698

 

95,055

Acquired in-process research and development

5,477

5,477

Other operating expenses

22,146

22,146

11,431

11,431

Total expenses

 

218,150

 

 

32,878

 

 

251,028

 

 

252,085

 

 

33,760

 

 

285,845

 

Operating loss

$

(147,888)

$

(6,088)

(153,976)

$

(164,005)

$

(9,051)

(173,056)

Other income (expense):

Interest expense

(28,637)

(25,593)

Foreign currency loss

(5,540)

(2,001)

Other income

511

392

Other income (expense), net

(33,666)

(27,202)

Loss before income taxes

(187,642)

(200,258)

Income tax benefit

127

125

Net loss

$

(187,515)

$

(200,133)